04/29/2025
12:27 PM | Compass Therapeutics (Filer)
| Form DEFA14A | |
04/29/2025
7:30 AM | Compass Therapeutics (Filer)
| Form DEF 14A | |
04/29/2025
7:30 AM | Compass Therapeutics (Filer)
| Form ARS | |
04/11/2025
6:37 PM | Compass Therapeutics (Issuer)
GORDON CARL L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
6:21 PM | Compass Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
04/11/2025
6:24 PM | Compass Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
5:51 PM | Compass Therapeutics (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2025
5:58 PM | Compass Therapeutics (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2025
8:25 AM | Compass Therapeutics (Issuer)
Lerner Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
8:30 AM | Anderman Jonathan (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
6:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CMPX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Compass Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/27/2025
5:39 AM | Compass Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
7:30 AM | Compass Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
7:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
4:10 PM | Compass Therapeutics (Issuer)
GRAY MARY ANN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:11 PM | Compass Therapeutics (Issuer)
Lerner Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:11 PM | Compass Therapeutics (Issuer)
LINDAHL RICHARD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:12 PM | Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:12 PM | Compass Therapeutics (Issuer)
Shin Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:05 PM | Boylan James P (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:08 PM | Compass Therapeutics (Issuer)
GORDON CARL L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:09 PM | Anderman Jonathan (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:09 PM | Chiniara Ellen (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:39 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Compass Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
9:37 AM | Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
4:17 PM | Compass Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
7:30 AM | Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
1:00 PM | Compass Therapeutics (Issuer)
Lerner Neil (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/10/2024
1:01 PM | Compass Therapeutics (Issuer)
Shin Barry (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/10/2024
1:02 PM | Compass Therapeutics (Issuer)
Shin Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
7:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
9:00 AM | Compass Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
09/08/2024
11:15 PM | Compass Therapeutics (Filer)
| Form EFFECT | |
08/30/2024
4:23 PM | Compass Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/14/2024
7:49 AM | Anderman Jonathan (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
7:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:00 AM | Compass Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/17/2024
7:32 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:09 PM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
05/13/2024
7:01 AM | Compass Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Buy CMPX Stock Free CMPX Stock Alerts